How does aging affect benzodiazepine pharmacokinetics and pharmacodynamics?

How does aging affect benzodiazepine pharmacokinetics and pharmacodynamics?

• A. Elderly patients require higher doses due to increased clearance.
• B. Pharmacokinetics are unchanged with age.
• C. Elderly patients cannot metabolize benzodiazepines at all.
• D. Elderly patients have decreased hepatic metabolism and increased sensitivity, requiring lower, titrated doses and slower administration.

Answer: (D)

Aging changes both how benzodiazepines are processed by the body and how the body responds to them. The liver’s ability to metabolize drugs declines with age due to reduced hepatic blood flow, enzyme activity, and overall liver function, which slows clearance and lengthens the drug’s half-life. This increases the chance of drug accumulation, especially with longer-acting benzodiazepines or active metabolites. At the same time, the elderly become more sensitive to the sedative and cognitive effects of these drugs because of age-related changes in brain receptors and neural processing. The combination means lower doses are often required, and you should titrate slowly and monitor carefully to minimize risks like excessive sedation, delirium, and falls. This is why the practice emphasizes starting with a small dose, increasing gradually, and considering agents with less metabolic burden when possible.

Aging changes both how benzodiazepines are processed by the body and how the body responds to them. The liver’s ability to metabolize drugs declines with age due to reduced hepatic blood flow, enzyme activity, and overall liver function, which slows clearance and lengthens the drug’s half-life. This increases the chance of drug accumulation, especially with longer-acting benzodiazepines or active metabolites. At the same time, the elderly become more sensitive to the sedative and cognitive effects of these drugs because of age-related changes in brain receptors and neural processing. The combination means lower doses are often required, and you should titrate slowly and monitor carefully to minimize risks like excessive sedation, delirium, and falls. This is why the practice emphasizes starting with a small dose, increasing gradually, and considering agents with less metabolic burden when possible.